Skip to main content

Table 4 Retrospective analysis of 232 lung adenocarcinoma patients by five binary classifiers. There were 80 patients in the control and 152 patients in the treatment

From: Subgroup identification for treatment selection in biomarker adaptive design

 

DLDA

ASD (−0.5,1)

ASD (−0.5,2)

ASD (−1,1)

ASD (−1,2)

Comparison 1

0.014

0.014

0.014

0.014

0.014

Comparison 4

0.018

0.049

0.014

NA

NA

Comparison 5

0.86

0.024

NA

NA

NA

Comparison 2

0.578

0.739

NA

NA

NA

Comparison 3

0.432

0.061

0.024

0.014

0.014

g+ (T)

3.40 (55)a

2.95 (118)

2.80 (146)

1.84 (152)

1.84 (152)

g+ (C)

2.36 (97)

1.98 (34)

1.16 (6)

NA (0)

NA (0)

g− (T)

3.82 (73)

3.89 (75)

3.46 (80)

3.46 (80)

3.46 (80)

g− (C)

3.35 (7)

2.02 (5)

NA (0)

NA (0)

NA (0)

  1. aMedian survival time (year) in the subgroup and the number of patients in the subgroup in parentheses